The interferon-stimulated gene Ifi27l2a restricts West Nile virus infection and pathogenesis in a cell-typeand region-specific manner

Journal of Virology

Volumn 90, Issue 5, 2016, Pages 2600-2615

  Lucas, Tiffany M ^a   Richner, Justin M ^a   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL PROTEIN; IFI27L2A PROTEIN; UNCLASSIFIED DRUG; INTERFERON; ISG12B1 PROTEIN, MOUSE; PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN STEM; CELL DEATH; CELLS BY BODY ANATOMY; CEREBELLUM; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; EMBRYO CELL; FEMALE; FIBROBLAST; FLAVIVIRIDAE INFECTION; GENE; GENE ACTIVATION; GENE IDENTIFICATION; GRANULE CELL; IFI27L2A GENE; INTERFERON STIMULATED GENE; LETHALITY; MACROPHAGE; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; SPINAL CORD; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; WEST NILE VIRUS; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY; WEST NILE FEVER;

ANIMALS; BRAIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, INNATE; INTERFERONS; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PROTEINS; SPINAL CORD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84961117135     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02463-15     Document Type: Article

References (71)

1. Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, Bergloff P, Crosby RD. 2006. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 43:723-730. http://dx.doi.org/10.1086/506939.
2. Chan CK, Limstrom SA, Tarasewicz DG, Lin SG. 2006. Ocular features of West Nile virus infection in North America: a study of 14 eyes. Ophthalmology 113:1539-1546. http://dx.doi.org/10.1016/j.ophtha.2006.04.021.
3. Leis AA, Fratkin J, Stokic DS, Harrington T, Webb RM, Slavinski SA. 2003. West Nile poliomyelitis. Lancet Infect Dis 3:9-10. http://dx.doi.org/10.1016/S1473-3099(03)00478-X.
4. Hainline ML, Kincaid JC, Carpenter DL, Golomb MR. 2008. West Nile poliomyelitis in a 7-year-old child. Pediatr Neurol 39:350-354. http://dx.doi.org/10.1016/j.pediatrneurol.2008.07.027.
5. Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H, Rutherford A, Astakhova NM, Perelygin AA, Busch MP, Murray KO, Sejvar JJ, Green S, Kriesel J, Brinton MA, Bamshad M. 2011. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One 6:e24745. http://dx.doi.org/10.1371/journal.pone.0024745.
6. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM. 2006. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203:35-40. http://dx.doi.org/10.1084/jem.20051970.
7. Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D, Stramer SL, Murphy PM. 2010. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 201:178-185. http://dx.doi.org/10.1086/649426.
8. Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM. 2009. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 5:e1000321. http://dx.doi.org/10.1371/journal.ppat.1000321.
9. Cho H, Diamond MS. 2012. Immune responses to West Nile virus infection in the central nervous system. Viruses 4:3812-3830. http://dx.doi.org/10.3390/v4123812.
10. Suen W, Prow N, Hall R, Bielefeldt-Ohmann H. 2014. Mechanism of West Nile virus neuroinvasion: a critical appraisal. Viruses 6:2796-2825. http://dx.doi.org/10.3390/v6072796.
11. Neal JW. 2014. Flaviviruses are neurotropic, but how do they invade the CNS? J Infect 69:203-215. http://dx.doi.org/10.1016/j.jinf.2014.05.010.
12. Suthar MS, Diamond MS, Gale M, Jr. 2013. West Nile virus infection and immunity. Nat Rev Microbiol 11:115-128. http://dx.doi.org/10.1038/nrmicro2950.
13. Cho H, Shrestha B, Sen GC, Diamond MS. 2013. A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol 87:8363-8371. http://dx.doi.org/10.1128/JVI.01097-13.
14. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med 19:458-464. http://dx.doi.org/10.1038/nm.3108.
15. Nair S, Michaelsen-Preusse K, Finsterbusch K, Stegemann-Koniszewski S, Bruder D, Grashoff M, Korte M, Köster M, Kalinke U, Hauser H, Kröger A. 2014. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog 10:e1003999. http://dx.doi.org/10.1371/journal.ppat.1003999.
16. Farmer JR, Altschaefl KM, O'Shea KS, Miller DJ. 2013. Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PLoS One 8:e58813. http://dx.doi.org/10.1371/journal.pone.0058813.
17. Rosato PC, Leib DA. 2014. Intrinsic innate immunity fails to control herpes simplex virus and vesicular stomatitis virus replication in sensory neurons and fibroblasts. J Virol 88:9991-10001. http://dx.doi.org/10.1128/JVI.01462-14.
18. Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. 2012. A neuronspecific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 12:334-345. http://dx.doi.org/10.1016/j.chom.2012.07.013.
19. Parker N, Porter A. 2004. Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12. BMC Genomics 5:8. http://dx.doi.org/10.1186/1471-2164-5-8.
20. Cheriyath V, Leaman DW, Borden EC. 2011. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. J Interferon Cytokine Res 31:173-181. http://dx.doi.org/10.1089/jir.2010.0105.
21. Rosebeck S, Leaman DW. 2008. Mitochondrial localization and proapoptotic effects of the interferon-inducible protein ISG12a. Apoptosis 13:562-572. http://dx.doi.org/10.1007/s10495-008-0190-0.
22. Li B, Shin J, Lee K. 2009. Interferon-stimulated gene ISG12b1 inhibits adipogenic differentiation and mitochondrial biogenesis in 3T3-L1 cells. Endocrinology 150:1217-1224. http://dx.doi.org/10.1210/en.2008-0727.
23. Martensen PM, Søgaard TMM, Gjermandsen IM, Buttenschøn HN, Rossing AB, Bonnevie-Nielsen V, Rosada C, Simonsen JL, Justesen J. 2001. The interferon alpha induced protein ISG12 is localized to the nuclear membrane. Eur J Biochem 268:5947-5954. http://dx.doi.org/10.1046/j.0014-2956.2001.02545.x.
24. Papac-Milicevic N, Breuss JM, Zaujec J, Ryban L, Plyushch T, Wagner GA, Fenzl S, Dremsek P, Cabaravdic M, Steiner M, Glass CK, Binder CJ, Uhrin P, Binder BR. 2012. The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circ Res 110:e50-e63. http://dx.doi.org/10.1161/CIRCRESAHA.111.258814.
25. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1:519-525. http://dx.doi.org/10.1016/j.coviro.2011.10.008.
26. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, Garcia-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-695.
27. Li J, Ding SC, Cho H, Chung BC, Gale M, Chanda SK, Diamond MS. 2013.Ashort hairpinRNAscreen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response. mBio 4:e00385-13. http://dx.doi.org/10.1128/mBio.00385-13.
28. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M. 2009. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50:1727-1737. http://dx.doi.org/10.1002/hep.23195.
29. Labrada L, Liang X, Zheng W, Johnston C, Levine B. 2002. Agedependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J Virol 76:11688-11703. http://dx.doi.org/10.1128/JVI.76.22.11688-11703.2002.
30. Mody M, Cao Y, Cui Z, Tay K-Y, Shyong A, Shimizu E, Pham K, Schultz P, Welsh D, Tsien JZ. 2001. Genome-wide gene expression profiles of the developing mouse hippocampus. Proc Natl Acad Sci U S A 98:8862-8867. http://dx.doi.org/10.1073/pnas.141244998.
31. Liu N, Zuo C, Wang X, Chen T, Yang D, Wang J, Zhu H. 2014. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT. Oncotarget 5:4959-4971. http://dx.doi.org/10.18632/oncotarget.2067.
32. Yang D, Meng X, Xue B, Liu N, Wang X, Zhu H. 2014. MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a. PLoS One 9:e94501. http://dx.doi.org/10.1371/journal.pone.0094501.
33. Tantawy MA, Hatesuer B, Wilk E, Dengler L, Kasnitz N, Weib S, Schughart K. 2014. The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection. PLoS One 9:e106392. http://dx.doi.org/10.1371/journal.pone.0106392.
34. Liu N, Long Y, Liu B, Yang D, Li C, Chen T, Wang X, Liu C, Zhu H. 2014. ISG12a mediates cell response to Newcastle disease viral infection. Virology 462-463:283-294.
35. Uhrin P, Perkmann T, Binder B, Schabbauer G. 2013. ISG12 is a critical modulator of innate immune responses in murine models of sepsis. Immunobiology 218:1207-1216. http://dx.doi.org/10.1016/j.imbio.2013.04.009.
36. Shrestha B, Diamond MS. 2004. Role of CD8+ T cells in control of West Nile virus infection. J Virol 78:8312-8321. http://dx.doi.org/10.1128/JVI.78.15.8312-8321.2004.
37. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M. 2006. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80: 9424-9434. http://dx.doi.org/10.1128/JVI.00768-06.
38. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. 2003. B cells and antibody play critical roles in the immediate defense of disseminated in-fection by West Nile encephalitis virus. J Virol 77:2578-2586. http://dx.doi.org/10.1128/JVI.77.4.2578-2586.2003.
39. Brien JD, Lazear HM, Diamond MS. 2013. Propagation, quantification, detection, and storage of West Nile virus. Curr Protoc Microbiol 31:15D.3.1-15D.3.18. http://dx.doi.org/10.1002/9780471729259.mc15d03s31.
40. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage HM, Komar N, Panella NA, Allen BC, Volpe KE, Davis BS, Roehrig JT. 2000. Rapid detection of West Nile virus from human clinical specimens, fieldcollected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38:4066-4071.
41. Daffis S, Samuel MA, Keller BC, Gale M, Jr, Diamond MS. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and-independent mechanisms. PLoS Pathog 3:e106. http://dx.doi.org/10.1371/journal.ppat.0030106.
42. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. 2005. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79:11457-11466. http://dx.doi.org/10.1128/JVI.79.17.11457-11466.2005.
43. Fuchs A, Pinto AK, Schwaeble WJ, Diamond MS. 2011. The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 412:101-109. http://dx.doi.org/10.1016/j.virol.2011.01.003.
44. Tacke F, Ginhoux F, Jakubzick C, van Rooijen N, Merad M, Randolph GJ. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med 203:583-597. http://dx.doi.org/10.1084/jem.20052119.
45. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327:656-661. http://dx.doi.org/10.1126/science.1178331.
46. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, Narni-Mancinelli E, Lauvau G. 2008. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 86:398-408. http://dx.doi.org/10.1038/icb.2008.19.
47. Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, Saederup N, Leemput J, Bigot K, Campisi L, Abitbol M, Molina T, Charo I, Hume DA, Cumano A, Lauvau G, Geissmann F. 2009. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med 206: 595-606. http://dx.doi.org/10.1084/jem.20081385.
48. Shrestha B, Pinto AK, Green S, Bosch I, Diamond MS. 2012. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J Virol 86:8937-8948. http://dx.doi.org/10.1128/JVI.00673-12.
49. Richner JM, Gmyrek GB, Govero J, Tu Y, van der Windt GJW, Metcalf TU, Haddad EK, Textor J, Miller MJ, Diamond MS. 2015. Agedependent cell trafficking defects in draining lymph nodes impair adaptive immunity and control of West Nile virus infection. PLoS Pathog 11: e1005027. http://dx.doi.org/10.1371/journal.ppat.1005027.
50. Mehlhop E, Diamond MS. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med 203:1371-1381. http://dx.doi.org/10.1084/jem.20052388.
51. Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M, Jr, Früh K, Diamond MS. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog 9:e1003118. http://dx.doi.org/10.1371/journal.ppat.1003118.
52. Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, Doyle SE, Gale M, Klein RS, Diamond MS. 2015. Interferon-restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med 7:284ra59. http://dx.doi.org/10.1126/scitranslmed.aaa4304.
53. Shrestha B, Samuel MA, Diamond MS. 2006. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 80:119-129. http://dx.doi.org/10.1128/JVI.80.1.119-129.2006.
54. Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P, Diamond MS. 2011. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol 85:11557-11566. http://dx.doi.org/10.1128/JVI.05519-11.
55. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja M-K, Diamond MS, Gale M, Jr. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 6:e1000757. http://dx.doi.org/10.1371/journal.ppat.1000757.
56. Daffis S, Suthar MS, Szretter KJ, Gale M, Jr, Diamond MS. 2009. Induction of IFN-β and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog 5:e1000607. http://dx.doi.org/10.1371/journal.ppat.1000607.
57. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79:13350-13361. http://dx.doi.org/10.1128/JVI.79.21.13350-13361.2005.
58. Lazear HM, Pinto AK, Vogt MR, Gale M, Diamond MS. 2011. Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol 85:7186-7194. http://dx.doi.org/10.1128/JVI.00396-11.
59. Suthar MS, Brassil MM, Blahnik G, Gale M. 2012. Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar. J Virol 86:7704-7709. http://dx.doi.org/10.1128/JVI.00401-12.
60. Shrestha B, Gottlieb DI, Diamond MS. 2003. Infection and injury of neurons by West Nile encephalitis virus. J Virol 77:13203-13213. http://dx.doi.org/10.1128/JVI.77.24.13203-13213.2003.
61. Samuel MA, Morrey JD, Diamond MS. 2007. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol 81:2614-2623. http://dx.doi.org/10.1128/JVI.02311-06.
62. Wie S-H, Du P, Luong TQ, Rought SE, Beliakova-Bethell N, Lozach J, Corbeil J, Kornbluth RS, Richman DD, Woelk CH. 2013. HIV downregulates interferon-stimulated genes in primary macrophages. J Interferon Cytokine Res 33:90-95. http://dx.doi.org/10.1089/jir.2012.0052.
63. Pommerenke C, Wilk E, Srivastava B, Schulze A, Novoselova N, Geffers R, Schughart K. 2012. Global transcriptome analysis in influenza-infected mouse lungs reveals the kinetics of innate and adaptive host immune responses. PLoS One 7:e41169. http://dx.doi.org/10.1371/journal.pone.0041169.
64. Clarke P, Leser JS, Bowen RA, Tyler KL. 2014. Virus-induced transcriptional changes in the brain include the differential expression of genes associated with interferon, apoptosis, interleukin 17 receptor A, and glutamate signaling as well as flavivirus-specific upregulation of tRNA synthetases. mBio 5:e00902-14. http://dx.doi.org/10.1128/mBio.00902-14.
65. Qi Y, Li Y, Zhang Y, Zhang L, Wang Z, Zhang X, Gui L, Huang J. 2015. IFI6 inhibits apoptosis via mitochondrial-dependent pathway in dengue virus 2 infected vascular endothelial cells. PLoS One 10:e0132743. http://dx.doi.org/10.1371/journal.pone.0132743.
66. Makovitzki-Avraham E, Daniel-Carmi V, Alteber Z, Farago M, Tzehoval E, Eisenbach L. 2013. The human ISG12a gene is a novel caspase dependent and p53 independent pro-apoptotic gene, that is overexpressed in breast cancer. Cell Biol Int Rep 20:37-46. http://dx.doi.org/10.1002/cbi3.10009.
67. Li S, Xie Y, Zhang W, Gao J, Wang M, Zheng G, Yin X, Xia H, Tao X. 2015. Interferon alpha-inducible protein 27 promotes epithelialmesenchymal transition and induces ovarian tumorigenicity and stemness. J Surg Res 193:255-264.
68. Hsieh WL, Huang YH, Wang TM, Ming YC, Tsai CN, Pang JHS. 2015. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif 48:187-197. http://dx.doi.org/10.1111/cpr.12168.
69. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. http://dx.doi.org/10.1038/nature09907.
70. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 8:e1002712. http://dx.doi.org/10.1371/journal.ppat.1002712.
71. Garcia MR, Ledgerwood L, Yang Y, Xu J, Lal G, Burrell B, Ma G, Hashimoto D, Li Y, Boros P, Grisotto M, van Rooijen N, Matesanz R, Tacke F, Ginhoux F, Ding Y, Chen SH, Randolph G, Merad M, Bromberg JS, Ochando JC. 2010. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 120:2486-2496. http://dx.doi.org/10.1172/JCI41628.